ACEA1021(redirected from 5-Nitro-6,7-Dichloro-1,4-Dihydro-2,3-Quinoxalinedione)
ACEA1021A selective antagonist at the strychnine-insensitive glycine site associated with the NMDA receptor complex which has in vivo neuroprotective effects in patients with ischaemic strokes and possibly also traumatic injury. There is currently very little clinical data to bring it forward as a therapeutic.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.